The above genes were, respectively, included in the OS survival analysis of AML patients and ALL patient, and the results showed that FLT3-ITD is the prognostic factor affecting the OS of AML patients, and E2A-PBX1 and DNMT3A are the prognostic factors affecting the OS of ALL patients (Tables 5, 6). This evidence concerns the gene PBX1 and acute lymphoblastic leukemia.